Stocks to sell

The stock market has been incredibly volatile in the past couple of months. Investors are anxious about a marked increase in Covid-19 cases due to the latest Delta variant. The variant has become a dominant strain even in countries with high vaccination rates. Moreover, the recent disappointing jobs data has also led to a slowdown

Every time that I’m asked to write about Ocugen (NASDAQ:OCGN) I must remind myself that OCGN stock was caught up in the meme-stock craze earlier this year. And with short interest in the stock still above 20%, I suppose there are several traders who have little choice other than to hold on and hope for the

Companies that have an economic moat have a competitive advantage over their rivals. Just as a physical moat protects a castle or fortress from outside threats, a moat around a company insulates it from threats posed by competing firms and economic conditions. While this can be an appealing feature for a company to have, antitrust

SOS Limited (NYSE:SOS) stock combines two themes Wall Street investors hate most right now: Bitcoin (CCC:BTC-USD) mining and China. Source: biggunsband / Shutterstock.com SOS is a Chinese Bitcoin miner. But wait, there’s more. SOS is a Chinese Bitcoin miner that has not delivered financial results for either quarter in 2021. It may not even be

Chinese stocks that ended up being targeted by Beijing have been pummeled in recent weeks. But after China’s government tried to reassure companies and investors that it was not trying to decimate the country’s stocks, some on Wall Street seem to believe that the government was giving the “all-clear” sign. But I don’t think that’s

Value investing and growth investing are two very popular strategies for investing in stocks. Nvidia (NASDAQ:NVDA) is a stock that can be easily fit in the growth stocks theme, but not value stocks. NVDA stock is trading at around $200 per share. The stock is up about 53% in 2021. But is it time to

Clover Health (NASDAQ:CLOV) stock burned bright for a brief period. Back in June, the shares rocketed from $7 up to $28 in a short period of time, thanks to a raging short squeeze. However, the huge rally came and went in the blink of an eye. Since then, CLOV stock has slumped back to $8.40

In pre-pandemic times, tech stocks were equated with long-term growth. For several decades, the sector led the way, rewarding investors with big returns. However, 2021 has seen many tech-focused companies struggle to maintain that momentum. Shares in many technology companies took a big hit in March during a general selloff in the sector. Not all

The whole fintech movement has been a popular theme for investors going back quite some time. One of the leading beneficiaries of this is SoFi Technologies (NASDAQ:SOFI) stock. Source: rafapress / Shutterstock.com SoFi is a financial services company offering a variety of consumer products. The product portfolio covers a number of services such as personal,

Meme stocks have dominated in 2021, and SOS Limited (NYSE:SOS) has benefited from the trend of irrational exuberance in investments. If you’re considering taking a position in SOS stock, there are a few things you should know first. Source: Mark Agnor / Shutterstock.com From its unfocused business model to its shaky fundamentals, SOS Limited is

As longtime readers know, I’m a huge electric vehicle (EV) stock bull. I’m 100% confident that electric vehicles will entirely replace gas-powered by cars by 2040, thanks to improving EV technology, falling battery costs, shifting consumer demand to eco-friendly products, and increasing supply of EVs. At this point, the EV Revolution is inevitable, and EV

Putting it simply, Vinco Ventures (NASDAQ:BBIG) is the kind of penny stock that’s a hard pass in normal market conditions. But, of course, what we have seen play out in the past year has been anything but normal. With phenomena like “meme stock madness,” rolling the dice on something like BBIG stock has become a

Last month, Marin Software (NASDAQ:MRIN) enjoyed a meme stock rally that made similar runs seem tame by comparison. But that doesn’t mean it’s wise to buy MRIN stock now as it crashes back to earth. The circumstances that helped the digital marketing software stock rise 16-fold aren’t likely to repeat themselves. Three factors worked in

Virgin Galactic (NYSE:SPCE) stock has been on a wild ride, but its heydays might be fading. Source: Brian Friedman / Shutterstock.com More than four decades ago, the musical act The Buggles released a song called Video Killed The Radio Star. A catchy little tune, the song carried a greater meaning (whether intentional or not) —

Back in January, I covered Sundial Growers (NASDAQ:SNDL) and wrote a bearish article. Essentially, I called SNDL stock a gamble. Now, seven months later, things have not changed much. Source: Shutterstock Of course, it’s hard for a company to present enough news and positive financial performance to radically change an investment thesis over such a

Bionano (NASDAQ:BNGO) is a small life sciences company. Biotech companies use Bionano’s Saphyr system for researching DNA and to diagnose illnesses caused by genetics. Up until recently, Bionano has had difficulty achieving widespread market adoption for Saphyr. However, BNGO stock has gone on a wild ride over the past year as traders gravitated to Bionano’s

There’s a lot of good news out there. But there’s also a lot of unknowns that keep buffeting that optimism. The other X-factor in all this is how the market is going to take any of the new information that gets released. Will an expanding economy be a bullish sign and move the market up?

Other than a short-lived rally in June fueled by Reddit users, ContextLogic (NASDAQ:WISH) stock is on a permanent trajectory downward. Source: sdx15 / Shutterstock.com WISH stock peaked at $32.85, shortly after its initial public offering earlier this year. The company’s unfavorable valuations, mixed first-quarter results, and poor sales forecast continue to weigh on its share

Over the last few weeks, there have been more than enough reasons to be skeptical about the record-breaking run in equities. Recently, I’ve been harping on the ridiculous amount of speculation in the market. But even more problematic is the Covid-19 pandemic. Just when you thought the crisis was fading into the rearview mirror, cases

With Covid-19 vaccination rates slowing around the world, now is not the time to buy biotechnology company Novavax (NASDAQ:NVAX) stock. Source: Ascannio/Shutterstock.com NVAX stock fell 10% between July 20 and July 27 as hope fades that the company will be able to get its Covid-19 vaccine to market in time to capitalize on demand for